CN101019926A - Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases and preparation method thereof - Google Patents
Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases and preparation method thereof Download PDFInfo
- Publication number
- CN101019926A CN101019926A CNA2007100133484A CN200710013348A CN101019926A CN 101019926 A CN101019926 A CN 101019926A CN A2007100133484 A CNA2007100133484 A CN A2007100133484A CN 200710013348 A CN200710013348 A CN 200710013348A CN 101019926 A CN101019926 A CN 101019926A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- micropowder
- radix
- traditional chinese
- percent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 36
- 208000024172 Cardiovascular disease Diseases 0.000 title claims abstract description 11
- 208000026106 cerebrovascular disease Diseases 0.000 title claims abstract description 11
- 230000002526 effect on cardiovascular system Effects 0.000 title claims abstract description 11
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 239000002775 capsule Substances 0.000 claims abstract description 14
- 239000008187 granular material Substances 0.000 claims abstract description 14
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 13
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 13
- 239000000203 mixture Substances 0.000 claims abstract description 10
- 239000003826 tablet Substances 0.000 claims abstract description 10
- 239000002552 dosage form Substances 0.000 claims abstract description 8
- 238000000605 extraction Methods 0.000 claims abstract description 8
- 241000208340 Araliaceae Species 0.000 claims description 18
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 18
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 18
- 235000008434 ginseng Nutrition 0.000 claims description 18
- 239000000796 flavoring agent Substances 0.000 claims description 16
- 235000019634 flavors Nutrition 0.000 claims description 16
- 241001489978 Eupolyphaga Species 0.000 claims description 12
- 241000237903 Hirudo Species 0.000 claims description 12
- 241000522620 Scorpio Species 0.000 claims description 12
- 239000009490 scorpio Substances 0.000 claims description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- 238000001035 drying Methods 0.000 claims description 9
- 239000000284 extract Substances 0.000 claims description 6
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 6
- 238000010992 reflux Methods 0.000 claims description 6
- 229940126678 chinese medicines Drugs 0.000 claims description 3
- 235000021050 feed intake Nutrition 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 239000008280 blood Substances 0.000 abstract description 21
- 210000004369 blood Anatomy 0.000 abstract description 21
- 230000000694 effects Effects 0.000 abstract description 9
- 230000017531 blood circulation Effects 0.000 abstract description 8
- 229940079593 drug Drugs 0.000 abstract description 7
- 230000002175 menstrual effect Effects 0.000 abstract description 6
- 230000003213 activating effect Effects 0.000 abstract description 5
- 238000007670 refining Methods 0.000 abstract description 5
- 208000001431 Psychomotor Agitation Diseases 0.000 abstract description 3
- 206010038743 Restlessness Diseases 0.000 abstract description 3
- 210000000988 bone and bone Anatomy 0.000 abstract description 3
- 230000001737 promoting effect Effects 0.000 abstract description 3
- 230000008961 swelling Effects 0.000 abstract description 3
- 241000131329 Carabidae Species 0.000 abstract 3
- 241000545744 Hirudinea Species 0.000 abstract 3
- 235000002789 Panax ginseng Nutrition 0.000 abstract 3
- 241000239226 Scorpiones Species 0.000 abstract 3
- 244000131316 Panax pseudoginseng Species 0.000 abstract 2
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract 2
- 240000007164 Salvia officinalis Species 0.000 abstract 2
- 235000005412 red sage Nutrition 0.000 abstract 2
- 230000004936 stimulating effect Effects 0.000 abstract 2
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 1
- 208000005392 Spasm Diseases 0.000 abstract 1
- 230000000740 bleeding effect Effects 0.000 abstract 1
- 230000001914 calming effect Effects 0.000 abstract 1
- 230000000295 complement effect Effects 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 210000003205 muscle Anatomy 0.000 abstract 1
- 244000132619 red sage Species 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 description 10
- 238000000034 method Methods 0.000 description 6
- 239000002994 raw material Substances 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 4
- 206010010904 Convulsion Diseases 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 239000000812 cholinergic antagonist Substances 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 206010015037 epilepsy Diseases 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 208000021760 high fever Diseases 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 230000003119 painkilling effect Effects 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000003389 potentiating effect Effects 0.000 description 2
- 230000002048 spasmolytic effect Effects 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases and a preparation method thereof, wherein the traditional Chinese medicine comprises the following main components in percentage by weight: 12 to 24 percent of red ginseng; 9 to 17 percent of pseudo-ginseng; 18 to 36 percent of salvia miltiorrhiza; 10% -20% of leech; 12 to 24 percent of scorpion; 6 to 12 percent of ground beetle; the dosage forms are capsules, tablets and granules. The efficacy of the traditional Chinese medicine formula is as follows: red ginseng: has the functions of invigorating primordial qi, restoring pulse, relieving depletion, invigorating qi, and controlling blood; pseudo-ginseng: the functions of eliminating blood stasis, stopping bleeding, reducing swelling and relieving pain; red sage root: the functions of removing blood stasis, relieving pain, promoting blood circulation, stimulating the menstrual flow, clearing away the heart-fire and relieving restlessness; leech: the functions of breaking blood, removing blood stasis and stimulating the menstrual flow; scorpion: has effects in calming endogenous wind, relieving spasm, removing toxic materials, resolving hard mass, dredging meridians, and relieving pain; ground beetle: functions of breaking blood stasis and reuniting bones and muscles. The Chinese medicine preparation is prepared with red ginseng, notoginseng, red sage, leech, scorpion and ground beetle and through processing, extraction, micronization and refining. The medicines are matched and complement each other, so that the traditional Chinese medicine composition has the effects of tonifying qi, activating blood circulation, removing blood stasis and dredging channels and collaterals, and is widely used for treating cardiovascular and cerebrovascular diseases.
Description
Technical field:
The present invention relates to a kind of Chinese medicine for the treatment of cardiovascular and cerebrovascular disease and preparation method thereof, Chinese medicine of particularly a kind of benefiting QI for activating blood circulation blood stasis dispelling the meridian dredging for the treatment of cardiovascular and cerebrovascular disease and preparation method thereof.
Background technology:
At present, the Chinese medicinal formulae of treatment cardiovascular and cerebrovascular disease in the prior art, recipe drug is processed at one tens flavor raw material of Chinese medicine, and prescription is big, compatibility amount complexity, the cost height, it is many to have side effects, and gives the patient and brings the overweight problem of financial burden.
Summary of the invention:
Purpose of the present invention provides a kind of Chinese medicine for the treatment of cardiovascular and cerebrovascular disease and preparation method thereof, it be Chinese medicine mainly by Radix Ginseng Rubra, Radix Notoginseng, Radix Salviae Miltiorrhizae, Hirudo, Scorpio, Eupolyphaga Seu Steleophaga Six-element raw material of Chinese medicine through the process of preparing Chinese medicine, extraction, micronization, processing and refining forms.Its dosage form comprises capsule, tablet, granule.Chinese medicinal formulae effect: Radix Ginseng Rubra: sweet, the little hardship of nature and flavor, temperature, return spleen, lung, heart channel, function strongly invigorating primordial QI, multiple arteries and veins take off admittedly, nourishing qi to stop; Radix Notoginseng: sweet, the little hardship of nature and flavor, temperature, return liver, stomach warp, the hemostasis of function dissipating blood stasis, subduing swelling and relieving pain; Radix Salviae Miltiorrhizae: the nature and flavor hardship, be slightly cold, GUIXIN, Liver Channel, function stasis-dispelling and pain-killing, promoting blood circulation to restore menstrual flow, relieving restlessness clears away heart-fire; Hirudo: nature and flavor are salty, bitter, flat, return Liver Channel, function removing blood stasis, removing blood stasis, stimulate the menstrual flow; Scorpio: nature and flavor suffering, flat, return Liver Channel, function relieve dizziness, high fever, infantile convulsions, epilepsy, etc. spasmolytic, dispersing pathogen accumulation, removing obstruction in the collateral to relieve pain; Eupolyphaga Seu Steleophaga: nature and flavor are salty, cold, return Liver Channel, function removing blood stasis with potent drugs blood, reuniting the fractured tendons and bones.Above Six-element drug matching brings out the best in each other, and gathers the effect of benefiting QI for activating blood circulation blood stasis dispelling the meridian dredging altogether.
The present invention realizes by the following technical solutions: it be Chinese medicine mainly by Radix Ginseng Rubra, Radix Notoginseng, Radix Salviae Miltiorrhizae, Hirudo, Scorpio, Eupolyphaga Seu Steleophaga Six-element raw material of Chinese medicine through the process of preparing Chinese medicine, extraction, micronization, processing and refining forms.Its dosage form comprises capsule, tablet, granule.The percentage by weight of its key component is: Radix Ginseng Rubra 12%-24%; Radix Notoginseng 9%-17%; Radix Salviae Miltiorrhizae 18%-36%; Hirudo 10%20%; Scorpio 12%-24%; Eupolyphaga Seu Steleophaga 6%-12%; Its dosage form is capsule and tablet and granule.Preparation method of Chinese medicine: after getting the process of preparing Chinese medicine of Radix Ginseng Rubra and Radix Salviae Miltiorrhizae, with medicinal 70%～95% alcohol reflux secondary, extracting solution filters, and reclaims ethanol, is condensed into thick paste, and drying is made micropowder; Radix Ginseng Rubra after the reflux, extract, and Radix Salviae Miltiorrhizae decoction dregs decoct with water the extraction secondary again, and decocting liquid filters, and is condensed into thick paste, and drying is made micropowder; Above two kinds of extractum micropowder mix homogeneously are promptly got Radix Ginseng Rubra and Radix Salviae Miltiorrhizae extract micropowder; Radix Notoginseng, Hirudo, Scorpio, Eupolyphaga Seu Steleophaga four flavor Chinese medicines are through concocting, and drying is made micropowder respectively; Get above-mentioned micropowder, feed intake mix homogeneously by the percentage by weight of component; Get the micropowder of mix homogeneously, be packed into capsule and promptly get capsule, perhaps add the compacting of an amount of pharmaceutic adjuvant and promptly get tablet in flakes, perhaps add an amount of pharmaceutic adjuvant and make granule and promptly get granule.
Effect of the present invention be Chinese medicine mainly by Radix Ginseng Rubra, Radix Notoginseng, Radix Salviae Miltiorrhizae, Hirudo, Scorpio, Eupolyphaga Seu Steleophaga Six-element raw material of Chinese medicine through the process of preparing Chinese medicine, extraction, micronization, processing and refining forms.Its dosage form comprises capsule, tablet, granule.All medicines match, and bring out the best in each other, and gather the effect of benefiting QI for activating blood circulation blood stasis dispelling the meridian dredging altogether, are widely used in the treatment of cardiovascular and cerebrovascular disease.
The specific embodiment:
Embodiments of the invention: it be Chinese medicine mainly by Radix Ginseng Rubra, Radix Notoginseng, Radix Salviae Miltiorrhizae, Hirudo, Scorpio, Eupolyphaga Seu Steleophaga Six-element raw material of Chinese medicine through the process of preparing Chinese medicine, extraction, micronization, processing and refining forms.Its dosage form comprises capsule, tablet, granule.The percentage by weight of its key component is: Radix Ginseng Rubra 12%-24%; Radix Notoginseng 9%-17%: Radix Salviae Miltiorrhizae 18%-36%; Hirudo 10%-20%; Scorpio 12%-24%; Eupolyphaga Seu Steleophaga 6%-12%; Its dosage form is capsule and tablet and granule.Preparation method of Chinese medicine: after getting the process of preparing Chinese medicine of Radix Ginseng Rubra and Radix Salviae Miltiorrhizae, with medicinal 70%～95% alcohol reflux secondary, extracting solution filters, and reclaims ethanol, is condensed into thick paste, and drying is made micropowder; Radix Ginseng Rubra after the reflux, extract, and Radix Salviae Miltiorrhizae decoction dregs decoct with water the extraction secondary again, and decocting liquid filters, and is condensed into thick paste, and drying is made micropowder; Above two kinds of extractum micropowder mix homogeneously are promptly got Radix Ginseng Rubra and Radix Salviae Miltiorrhizae extract micropowder; Radix Notoginseng, Hirudo, Scorpio, Eupolyphaga Seu Steleophaga four flavor Chinese medicines are through concocting, and drying is made micropowder respectively; Get above-mentioned micropowder, feed intake mix homogeneously by the percentage by weight of component; Get the micropowder of mix homogeneously, be packed into capsule and promptly get capsule, perhaps add the compacting of an amount of pharmaceutic adjuvant and promptly get tablet in flakes, perhaps add an amount of pharmaceutic adjuvant and make granule and promptly get granule.Chinese medicinal formulae effect of the present invention: Radix Ginseng Rubra: sweet, the little hardship of nature and flavor, temperature, return spleen, lung, heart channel, function strongly invigorating primordial QI, multiple arteries and veins take off admittedly, nourishing qi to stop; Radix Notoginseng: sweet, the little hardship of nature and flavor, temperature, return liver, stomach warp, the hemostasis of function dissipating blood stasis, subduing swelling and relieving pain; Radix Salviae Miltiorrhizae: the nature and flavor hardship, be slightly cold, GUIXIN, Liver Channel, function stasis-dispelling and pain-killing, promoting blood circulation to restore menstrual flow, relieving restlessness clears away heart-fire; Hirudo: nature and flavor are salty, bitter, flat, return Liver Channel, function removing blood stasis, removing blood stasis, stimulate the menstrual flow; Scorpio: nature and flavor suffering, flat, return Liver Channel, function relieve dizziness, high fever, infantile convulsions, epilepsy, etc. spasmolytic, dispersing pathogen accumulation, removing obstruction in the collateral to relieve pain; Eupolyphaga Seu Steleophaga: nature and flavor are salty, cold, return Liver Channel, function removing blood stasis with potent drugs blood, reuniting the fractured tendons and bones.Above Six-element drug matching brings out the best in each other, and gathers the effect of benefiting QI for activating blood circulation blood stasis dispelling the meridian dredging altogether.
Claims (2)
1, a kind of Chinese medicine for the treatment of cardiovascular and cerebrovascular disease and preparation method thereof is characterized in that the percentage by weight of key component is: Radix Ginseng Rubra 12%-24%; Radix Notoginseng 9%-17%; Radix Salviae Miltiorrhizae 18%-36%; Hirudo 10%20%; Scorpio 12%-24%; Eupolyphaga Seu Steleophaga 6%-12%; Its dosage form is capsule and tablet and granule.
2, a kind of Chinese medicine for the treatment of cardiovascular and cerebrovascular disease according to claim 1 and preparation method thereof is after it is characterized in that getting Radix Ginseng Rubra and Radix Salviae Miltiorrhizae and concocting, with medicinal 70%～95% alcohol reflux secondary, extracting solution filters, and reclaims ethanol, is condensed into thick paste, drying is made micropowder; Radix Ginseng Rubra after the reflux, extract, and Radix Salviae Miltiorrhizae decoction dregs decoct with water the extraction secondary again, and decocting liquid filters, and is condensed into thick paste, and drying is made micropowder; Above two kinds of extractum micropowder mix homogeneously are promptly got Radix Ginseng Rubra and Radix Salviae Miltiorrhizae extract micropowder; Radix Notoginseng, Hirudo, Scorpio, Eupolyphaga Seu Steleophaga four flavor Chinese medicines are through concocting, and drying is made micropowder respectively; Get above-mentioned micropowder, feed intake mix homogeneously by the percentage by weight of component; Get the micropowder of mix homogeneously, be packed into capsule and promptly get capsule, perhaps add the compacting of an amount of pharmaceutic adjuvant and promptly get tablet in flakes, perhaps add an amount of pharmaceutic adjuvant and make granule and promptly get granule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2007100133484A CN101019926A (en) | 2007-02-13 | 2007-02-13 | Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2007100133484A CN101019926A (en) | 2007-02-13 | 2007-02-13 | Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101019926A true CN101019926A (en) | 2007-08-22 |
Family
ID=38707852
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2007100133484A Pending CN101019926A (en) | 2007-02-13 | 2007-02-13 | Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101019926A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103393753A (en) * | 2013-07-16 | 2013-11-20 | 侯晓峰 | Traditional Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases |
| CN104523861A (en) * | 2014-12-31 | 2015-04-22 | 田元生 | Traditional Chinese medicine combination used for treating stroke and preparation method thereof |
| CN104523856A (en) * | 2014-12-09 | 2015-04-22 | 周树强 | Yi medicine for treating cerebral thrombosis and cerebral hemorrhage sequela |
| CN116920040A (en) * | 2023-08-31 | 2023-10-24 | 浙江工业大学 | Traditional Chinese medicine composition for treating acute myocardial infarction and preparation and application thereof |
-
2007
- 2007-02-13 CN CNA2007100133484A patent/CN101019926A/en active Pending
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103393753A (en) * | 2013-07-16 | 2013-11-20 | 侯晓峰 | Traditional Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases |
| CN103393753B (en) * | 2013-07-16 | 2015-03-25 | 侯晓峰 | Traditional Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases |
| CN104523856A (en) * | 2014-12-09 | 2015-04-22 | 周树强 | Yi medicine for treating cerebral thrombosis and cerebral hemorrhage sequela |
| CN104523861A (en) * | 2014-12-31 | 2015-04-22 | 田元生 | Traditional Chinese medicine combination used for treating stroke and preparation method thereof |
| CN116920040A (en) * | 2023-08-31 | 2023-10-24 | 浙江工业大学 | Traditional Chinese medicine composition for treating acute myocardial infarction and preparation and application thereof |
| CN116920040B (en) * | 2023-08-31 | 2024-04-19 | 浙江工业大学 | Traditional Chinese medicine composition for treating acute myocardial infarction and preparation and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101066303B (en) | Medicine for treating cerebral thrombus, cerebral angiosclerosis, apoplexy and hemiplegia and its preparation | |
| CN103386022B (en) | Chinese medicine composition for treating tuberculous pleurisy | |
| CN100396328C (en) | Combined medicine for preventing and treating rheumatism, rheumatoid, protrusion of intervertebral disc and hyperosteogeny | |
| CN102284022A (en) | Cough medicament and preparation method thereof | |
| CN104013929B (en) | Rheumatism pain relief medicine for treating rheumatic arthritis and rheumatoid arthritis and preparation method thereof | |
| CN101019926A (en) | Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases and preparation method thereof | |
| CN102068527A (en) | Medicine and treatment method for eradication of whelk | |
| CN105250427A (en) | Pharmaceutical composition for treating heart diseases | |
| CN105326939A (en) | Traditional Chinese medicine for treating heart and cerebral vusculer diseases | |
| CN101664490B (en) | Preparation for treating rheumatism and rheumatoid pain | |
| CN103751547A (en) | Traditional Chinese medicinal composition for reducing blood lipid and preparation method thereof | |
| CN1440804A (en) | Antilipemic Chinese medicine | |
| CN1182866C (en) | Medicinal liquor for curing rheumatism and traumatic injuries | |
| CN105497351A (en) | Traditional Chinese medicine composition for treating facioplegia and preparation method thereof | |
| CN110711235A (en) | Tianshen blood pressure reducing capsule for calming liver, stopping endogenous wind, dredging collaterals, promoting qi circulation, activating blood circulation and removing blood stasis | |
| CN1634194A (en) | Genital disease treating Chinese medicine | |
| CN103784879A (en) | Compound traditional Chinese medicinal preparation for treating ischemic cerebrovascular diseases | |
| CN1235605C (en) | Medicinal composition for treating gall | |
| CN101194963B (en) | Process for preparing medicine for treating headache | |
| CN100571739C (en) | Herbal mixture of treatment cardiovascular disease and preparation method thereof | |
| CN105395793A (en) | Application of traditional Chinese medicine composition to preparing medicine treating chronic stable angina pectoris | |
| CN1225269C (en) | Medicine for treating prospoalgia | |
| CN106853193A (en) | It is a kind of to treat Chinese medicine of rheumatoid arthritis and preparation method thereof | |
| CN1217692C (en) | A Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases and protecting health, and its preparation method | |
| CN109771624A (en) | A kind of Chinese medicine composition for treating apoplexy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20070822 |